146 related articles for article (PubMed ID: 23981985)
1. Effect of UGT2B7 genetic variants on serum valproic acid concentration.
Ma H; Zhang T; Gong Z; Zhou B; Zou M; Xiao S; Zhu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):766-72. PubMed ID: 23981985
[TBL] [Abstract][Full Text] [Related]
2. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients.
Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ
Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889
[TBL] [Abstract][Full Text] [Related]
3. Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.
Du Z; Jiao Y; Shi L
Med Sci Monit; 2016 Oct; 22():4107-4113. PubMed ID: 27795544
[TBL] [Abstract][Full Text] [Related]
4. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
[TBL] [Abstract][Full Text] [Related]
5. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
6. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
[TBL] [Abstract][Full Text] [Related]
7. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
8. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy.
Zhao M; Chen Y; Wang M; Li G; Zhao L
Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351
[TBL] [Abstract][Full Text] [Related]
9. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
[TBL] [Abstract][Full Text] [Related]
10. Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B
Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730
[TBL] [Abstract][Full Text] [Related]
11. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP
Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
13. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
Guo Y; Hu C; He X; Qiu F; Zhao L
Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L
Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variants in six candidate genes with valproic acid therapy optimization.
Hung CC; Ho JL; Chang WL; Tai JJ; Hsieh TJ; Hsieh YW; Liou HH
Pharmacogenomics; 2011 Aug; 12(8):1107-17. PubMed ID: 21806385
[TBL] [Abstract][Full Text] [Related]
16. UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy.
Nandith PB; Adiga U; Shenoy V; Adiga M N S
Indian J Pediatr; 2021 Aug; 88(8):764-770. PubMed ID: 33400134
[TBL] [Abstract][Full Text] [Related]
17. Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients.
Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Tang J; Xiao J; Chen XP
Pharmacogenomics; 2016 Jul; 17(11):1219-1225. PubMed ID: 27406852
[TBL] [Abstract][Full Text] [Related]
18. Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy.
Wang Y; Li Z
Therapie; 2020; 75(3):261-270. PubMed ID: 31474408
[TBL] [Abstract][Full Text] [Related]
19. Influence of
Du Z; Xu H; Zhao P; Wang J; Xu Q; Liu M
Xenobiotica; 2021 Jul; 51(7):859-864. PubMed ID: 34000957
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]